Download presentation
Presentation is loading. Please wait.
1
Primary care and AKI test results:
Guidance and support Richard Fluck Chair Think Kidneys 15th March 2016
2
Coming soon! 4th April 2016 Guidance for Primary Care in responding to the e-Alerts Medicines Optimisation for Primary Care Primary Care Risk Matrix STOP at risk of AKI cards AKi and Primary Care: Richard Fluck 20/05/2019
3
Think Kidneys: Best Practice Guidance
AKi and Primary Care: Richard Fluck 20/05/2019
4
Aims: Put the test result in a clinical context
Treat the patient not the test result Maximise clinical utility Minimise information overload and burden Ensure primary care engagement AKi and Primary Care: Richard Fluck 20/05/2019
5
10 Key Steps: Development of Guidance: led by Tom Blakeman
Step 1: Form Think Kidney Primary Care Working Group Step 2: Review existing local and national AKI guidelines Step 3: Identify and align with other relevant guidelines Step 4: Conduct RAND Consensus Process Step 5: Develop early drafts Step 6: First Round of National Feedback Step 7: Think Kidneys Primary Care Resource Workshop Step 8: Multidisciplinary meeting 1 (North East) Step 9: Multidisciplinary meeting 2 (Out of Hours -Bristol) Step 10: Second round of National Feedback AKi and Primary Care: Richard Fluck 20/05/2019
6
Step 1: Form Think Kidneys Primary Care Working Group
April 2015 AKi and Primary Care: Richard Fluck 20/05/2019
7
Step 4: Conduct RAND Consensus Process
Panel Membership: Clinical Biochemistry Acute & Emergency Medicine Routine General Practice: Out of Hours Care GP Commissioning Medical ‘overdiagnosis’ A 10-person panel was identified with representation from clinical biochemistry, acute and emergency medicine and routine general practice. Individuals with an expressed interest and expertise in AKI through membership of the Think Kidneys Programme were invited as well as general practitioners who represented typical practice in relation to out of hours care, GP commissioning and those who represented a medical ‘over-diagnosis’ perspective. The panel was co-chaired by one researcher (SC), who is expert in the RAND Appropriateness Method, and a nephrologist (CT) who is expert in AKI. July-September 2015 AKi and Primary Care: Richard Fluck 20/05/2019
8
A NOT SO HANDY GUIDE! Step 6: Invite feedback
November 2015-January 2016 AKi and Primary Care: Richard Fluck 20/05/2019
9
Think Kidneys: Best Practice Guidance
March 2016 AKi and Primary Care: Richard Fluck 20/05/2019
10
Think Kidneys: Best Practice Guidance
March 2016 AKi and Primary Care: Richard Fluck 20/05/2019
11
Think Kidneys: Best Practice Guidance
March 2016 AKi and Primary Care: Richard Fluck 20/05/2019
12
Think Kidneys: Medicines Optimisation
Publication 4th April, 2016 AKi and Primary Care: Richard Fluck 20/05/2019
13
Drugs and the relationship with kidneys
Avoid the term ‘nephrotoxic’ Effects of renal physiology, volume, electrolytes Does the side effect profile change? Any actions direct on the kidneys? AKi and Primary Care: Richard Fluck 20/05/2019
14
Medicines optimisation
AKi and Primary Care: Richard Fluck 20/05/2019
15
Patient information AKi and Primary Care: Richard Fluck 20/05/2019
16
Patient information AKi and Primary Care: Richard Fluck 20/05/2019
17
STOP AKI risk cards: in pilot
AKi and Primary Care: Richard Fluck 20/05/2019
18
Infographic on the kidneys: working with the public
AKi and Primary Care: Richard Fluck 20/05/2019
19
Coming soon! 4th April 2016 Guidance for Primary Care in responding to the e-Alerts Medicines Optimisation for Primary Care Primary Care Risk Matrix STOP at risk of AKI cards AKi and Primary Care: Richard Fluck 20/05/2019
20
Contact Think Kidneys How to find out more Karen Thomas
Think Kidneys Programme Manager UK Renal Registry Teresa Wallace Think Kidneys Programme Coordinator Richard Fluck National Clinical Director for Renal NHS England Joan Russell Head of Patient Safety Ron Cullen Director UK Renal Registry AKi and Primary Care: Richard Fluck 20/05/2019
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.